Every claim traced to its primary source, graded for evidence quality, shown openly.
A peer-reviewed risk assessment in Carcinogenesis, led by UNSW Sydney (March 30, 2026), judged nicotine e-cigarettes "likely to be carcinogenic," based on biomarker, animal, and mechanistic data.
In RASolute 302, a Phase 3 trial of 500 patients with treated RAS-mutant pancreatic cancer, daraxonrasib raised median survival to 13.2 vs 6.6 months on chemo, a 60% lower death risk.
Peer-reviewed audits show that AI systems will produce convincing medical disinformation on request, complete with fabricated citations and invented clinician testimonials.
In a placebo-controlled trial of 82 adults with anhedonic depression, the dopamine drug pramipexole cut pleasure-scale scores 4.04 points more than placebo over 9 weeks.
Latest